1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Wei-Che Ko: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Squaric Acid Dibutyl Ester, Known patch test allergens, Dupilumab - Skin Inflammation, Allergic Contact Dermatitis | Phase 2 / Phase 3 | Active not recruiting | Wei-Che Ko | 45 | 2022-11-15 | 2026-06-09 |
Dermatitis (1) · Dermatitis, Allergic Contact (1)
Adalimumab (1) · Betamethasone Valerate (1) · Fluticasone (1) · Triamcinolone Acetonide (1) · Ustekinumab (1) · canakinumab (1) · dupilumab (1) · guselkumab (1) · sarilumab (1) · squaric acid dibutyl ester (1)
United States (1)